2
Total deals
$84.2M
Total value
$84.2M
Avg deal
$84.2M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
TxCell
TxCell develops cell-based immuno-therapies for the treatment of severe chronic …
|
2018-07-23 | Acquisition | Complete | $84.2M | Deal → |
| 2 |
Ceregene
Ceregene is a biotechnology company that treats neurodegenerative disorders usin…
|
2013-08-26 | Acquisition | Complete | — | Deal → |